Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell GeneDx Holdings Corp (WGS) – GeneDx Holdings Corp Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

GeneDx (WGS) trades at $65.96, up 0.83% on the day, with strong analyst support including a consensus price target of $138.75 indicating significant upside potential. Recent earnings beats in Q2-Q4 2025 and positive news flow around genetic testing advancements highlight growth momentum, though negative profitability metrics and high valuation ratios present fundamental challenges.
The outlook is bullish based on analyst consensus and institutional accumulation, but risks include persistent net losses, competitive pressures in genomics, and reliance on continued revenue growth to justify current valuations. Key catalysts include the Q1 2026 earnings release on May 4, 2026.
Read full analysis

Key Stats

  • Market Cap
    $1.93B
  • Sector
    Technology
  • 3M Drawdown
    -45.57%
  • Enterprise Value
    $1.87B
  • Dividend Yield
    -
$63.98
52W Low: $56.36
08 May 2025
52W High: $167.51
25 Nov 2025

GeneDx Holdings Corp (WGS) is currently valued at a market capitalization of $1.93B, with an enterprise value of $1.87B. Over the past 52 weeks, GeneDx Holdings Corp has traded between a low of $56.36 and a high of $167.51, highlighting its annual price range. Over the past three months, GeneDx Holdings Corp has recorded a drawdown of -45.57%, reflecting recent price volatility.

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.


Technical Indicators
|
|
|
Overall Summary
Bearish (10)Neutral (10)Bullish (3)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $1.93B
  • Sector
    Technology
  • 3M Drawdown
    -45.57%
  • Enterprise Value
    $1.87B
  • Dividend Yield
    -
$63.98
52W Low: $56.36
08 May 2025
52W High: $167.51
25 Nov 2025

GeneDx Holdings Corp (WGS) is currently valued at a market capitalization of $1.93B, with an enterprise value of $1.87B. Over the past 52 weeks, GeneDx Holdings Corp has traded between a low of $56.36 and a high of $167.51, highlighting its annual price range. Over the past three months, GeneDx Holdings Corp has recorded a drawdown of -45.57%, reflecting recent price volatility.

Let’s invest in this asset by signing up or download!